Hot Natural Products & Bioactive Compounds

BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.

Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.

Hot Products from BioCrick

Showing 1201 - 1208 of 9359 hot products

BioCrick hot natural products and bioactive compounds
Catalog No. Product Name
BCC5470 Benoxafos
Benoxafos is an insecticide.
BCC5473 Cloxyfonac
Cloxyfonac is a plant growth regulator and a chemical transformation product; Pesticide agent.
BCC5476 Aldicarb sulfone
Aldicarb sulfone(Temik sulfone) is a carbamate insecticide; is a cholinesterase inhibitor which prevents the breakdown of acetylcholine in the synapse.
BCC5477 NSC-41589
N-[2-(methylsulfanyl) phenyl]acetamide.
BCC5482 SF1670
PTPN2 and PTEN inhibitor (IC50values are 0.95 and 1.78 μM, respectively). Increases fMLP-elicited PIP3 signaling, Akt -phosphorylation and production of reactive oxygen species in neutrophils in vitro. Pretreatment of transfused neutrophils enhances chemotaxis to sites of bacterial infection and increases survival in neutropenic mice. Also inhibits CD45.
BCC5484 Phosphoramidon Disodium Salt
Neutral endopeptidase (neprilysin) inhibitor. Blocks degradation of amyloid β peptides and increases Aβ levels in rodents. Also blocks endothelin converting enzyme (ECE).
BCC5486 SB-3CT
Selective high affinity MMP2 inhibitor (Ki = 28 nM); also inhibits MMP9 (Ki = 400 nM). Active in vivo, neuroprotective and blood-brain barrier permeable.
BCC5504 ESI-09
EPAC inhibitor. Inhibits EPAC-mediated insulin releases from pancreatic <span class='symbol'>&#946;</span> cells. Selective for EPAC over PKA. Decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells <em>in vitro</em>.